MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients

Clinical trial NCT04651634 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04651634
Sponsor: MitoImmune Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Oral Mucositis

Start date: 2021-06-21
Primary completion: 2025-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.